Nitric Oxide-Based Medicine

We use our proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs.

Press Releases

October 18, 2019

Novan Further Expands its Proprietary Nitric Oxide Platform
October 8, 2019

Novan’s Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology
September 20, 2019

Novan Awarded Approximately $1.1 Million Grant by Department of Defense

Carri Geer